Company profile for Qynapse

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Qynapse is a medical technology company that provides a cloud-based platform for the diagnosis, prognosis and drug efficacy measurement for central nervous system diseases (such as multiple sclerosis, Alzheimer's, Parkinson's and ischemic stroke).Qynapse is a spin-off of the CATI consortium of neuroimaging research laboratories and is headquartered in Paris. Qynapse is a medical technology company that unlocks the potential of...
Qynapse is a medical technology company that provides a cloud-based platform for the diagnosis, prognosis and drug efficacy measurement for central nervous system diseases (such as multiple sclerosis, Alzheimer's, Parkinson's and ischemic stroke).Qynapse is a spin-off of the CATI consortium of neuroimaging research laboratories and is headquartered in Paris. Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
130 rue de Lourmel 75015 Paris France
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/qynapse-to-present-symposium-oral-and-poster-presentations-at-adpd-2022-international-conference-301495027.html

PRNEWSWIRE
03 Mar 2022

https://www.prnewswire.com/news-releases/qynapse-to-present-new-evidence-on-the-value-of-qyscore-for-the-diagnosis-and-monitoring-of-multiple-sclerosis-at-actrims-forum-2022-301481763.html

PRNEWSWIRE
14 Feb 2022

https://www.prnewswire.com/news-releases/qynapse-to-sponsor-and-present-new-data-on-qypredict-at-clinical-trials-on-alzheimers-disease-conference-ctad-2021-301416302.html

PRNEWSWIRE
04 Nov 2021

https://www.prnewswire.com/news-releases/qynapse-further-strengthens-its-executive-leadership-team-with-the-appointment-of-adam-schwarz-phd-as-chief-scientific-officer-301405664.html

PRNEWSWIRE
21 Oct 2021

https://www.prnewswire.com/news-releases/qynapse-to-present-poster-presentations-and-attend-the-alzheimers-association-international-conference-aaic-2021-in-denver-usa-and-online-301340499.html

PRNEWSWIRE
26 Jul 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty